An Animal Model for Assessing the Effects of Hydroxyurea Exposure Suggests That the Administration of This Agent to Pregnant Women and Young Infants May Not Be as Safe as We Thought

The cytostatic agent hydroxyurea (HU) has proven to be beneficial for a variety of conditions in the disciplines of oncology, hematology, infectious disease and dermatology. It disrupts the S phase of the cell cycle by inhibiting the ribonucleotide reductase enzyme, thus blocking the transformation...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Vázquez, Lucía, Martí, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320814/
https://www.ncbi.nlm.nih.gov/pubmed/30544930
http://dx.doi.org/10.3390/ijms19123986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320814/
https://www.ncbi.nlm.nih.gov/pubmed/30544930
http://dx.doi.org/10.3390/ijms19123986

Ejemplares similares